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This is the first case of Plasmodium knowlesi infection in a Japanese traveller returning from Malaysia. In September
2012, a previously healthy 35-year-old Japanese man presented to National Center for Global Health and Medicine
in Tokyo with a two-day history of daily fever, mild headaches and mild arthralgia. Malaria parasites were found in
the Giemsa-stained thin blood smear, which showed band forms similar to Plasmodium malariae. Although a
nested PCR showed the amplification of the primer of Plasmodium vivax and Plasmodium knowlesi, he was finally
diagnosed with P. knowlesi mono-infection by DNA sequencing. He was treated with mefloquine, and recovered
without any complications. DNA sequencing of the PCR products is indispensable to confirm P. knowlesi infection,
however there is limited access to DNA sequencing procedures in endemic areas. The extent of P. knowlesi
transmission in Asia has not been clearly defined. There is limited availability of diagnostic tests and routine
surveillance system for reporting an accurate diagnosis in the Asian endemic regions. Thus, reporting accurately
diagnosed cases of P. knowlesi infection in travellers would be important for assessing the true nature of this
emerging human infection.
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The first naturally acquired zoonotic infection with Plas-
modium knowlesi in a human was reported in 1965 [1];
thereafter, no such infections were reported for almost
40 years. In 2004, however, Singh et al. [2] reported that
natural P. knowlesi infections in humans were common
parasite species in Malaysia. Cox-Singh et al. [3] subse-
quently described that P. knowlesi infections in humans
were observed throughout wide areas of Southeast Asia,
including Thailand, Myanmar, the Philippines, Singapore
and Indonesia. Additionally, 12 cases of P. knowlesi in-
fection in travellers have been reported from non-
malaria endemic countries thus far [1,4-14]. Here, this is
the first confirmed case of P. knowlesi infection in a
Japanese traveller.* Correspondence: k_taro023@yahoo.co.jp
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In September 2012, a previously healthy 35-year-old
Japanese man presented to the travel clinic in National
Center for Global Health and Medicine (NCGM), Tokyo
with a two-day history of daily fever, mild headache, and
mild arthralgia. He had visited Malaysia for entomo-
logical and botanical field investigations over a two-
month period and had stayed at Temengor (four weeks),
Johor (two weeks), and Kuala Lumpur (two weeks).
While in Temengor, he stayed in a tent located near a
forest and had not used any malaria prevention mea-
sures, such as bed nets, mosquito repellents or che-
moprophylaxis. During his stay, he was bitten by
mosquitoes and saw some wild monkeys. He had no
health problems and was in a good physical condition
until he experienced a sudden high fever (39.0°C axillary
temperature) the day after his return to Japan. He had
fever spikes of >38.0°C in a 24-hour period. On the third
day of his illness, he was admitted to NCGM. On admis-
sion his body temperature was 37.0°C, with blood pres-
sure of 111/80 mmHg, pulse rate of 115 beats per
minute, respiration rate of 16 per minute, and oxygenl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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vealed mild splenomegaly and left upper abdominal pain.
Laboratory investigations showed thrombocytopenia
(47 × 103 cells/mm3, reference range 150–350 cells/
mm3), elevated liver enzymes (serum aspartate amino-
transferase 49 U/L, reference range 13–33 U/L; alanine
aminotransferase 41 U/L, reference range 8–42 U/L; al-
kaline phosphatase 428 U/L, reference range 115–359
U/L; and total bilirubin 1.1 mg/dl, reference range 0.3-
1.2 mg/dl), a high C-reactive protein level (11.59 mg/dl,
reference range 0–0.3 mg/dl), no anaemia (haemoglobin
17.3 g/dl, reference range 13.5-17.0 g/dl), and a normal
leukocyte count (3,860 cells/mm3, reference range 3,500-
8,500/mm3). The patient’s free blood glucose levels and
renal function were normal. Although rapid diagnostic
tests (BinaxNOW MalariaW; Alere, Inc, Scarborough,
USA) for the Plasmodium falciparum histidine-rich pro-
tein 2 and pan-malarial aldolase were negative, malaria
parasites were identified in the patient’s Giemsa-stained
thin blood smear from which a parasitaemia of 0.2%
(10,120 parasites/μl) was calculated. The morphological
features of the parasites comprised band forms, whichFigure 1 Microscopic analysis of Giemsa-stained thin blood-smears fr
parasites. The blood smears were taken before (A), four hours after (B), an
treatment the following blood-stage parasites were observed: a) band form
the ring forms (d, e, g, h) and trophozoites (f, i) gradually changed into irre
0.2%, 0.05%, and 0.013%, respectively.are similar to those characteristics of Plasmodium
malariae, and heavily pigmented schizonts inside non-
enlarged erythrocytes (Figure 1). To make a definitive
diagnosis, two partial gene regions (the small subunit
rRNA from nuclear DNA and cytochrome b from mito-
chondrial DNA) from five malaria parasite species were
tried to be amplified by nested PCR, using respective
primer sets for P. falciparum, Plasmodium vivax, Plas-
modium ovale, P. malariae and P. knowlesi. The positive
result was obtained by the primer sets of P. knowlesi and
P. vivax in the amplification of the partial small subunit
rRNA gene. However, in the amplification of the partial
cytochrome b gene, the positive result was obtained by
the P. knowlesi primer sets (Figure 2). The sequences of
the PCR products were determined using an ABI 3130xl
Genetic Analyzer (Applied Biosystems, CA, USA) after
TA cloning. From this sequence analysis, the patient was
confirmed that even the PCR product amplified by the
P. vivax primer sets for the partial small subunit rRNA
gene was proved to be the DNA of P. knowlesi. He was
treated with mefloquine (1,500 mg base), then was re-
peated the microscopic screening for parasites everyom a patient infected with Plasmodium knowlesi malaria
d 16 hours after treatment (C), respectively. A) Before mefloquine
, b) ring form, and c) schizont. B, C) Post-mefloquine treatment (B, C),
gular forms. The parasitaemias calculated from slides A, B, and C were
Figure 2 Nested PCR results from the inner primers. The region amplified was a partial sequence of the cytochrome b gene (mitochondrial
DNA) from different malaria parasite species (~130-180 bp). M: DNA size marker, P: patient, Pf: Plasmodium falciparum, Pv: Plasmodium vivax, Po:
Plasmodium ovale, Pm: Plasmodium malariae and, Pk: Plasmodium knowlesi. PC: positive control, NC: negative control. Forward primers for the
outer PCR and the inner PCR were the same as those reported by Putaporntip et al. [15]. The sequences of the reverse primers used for the outer
PCR and the inner PCR are as follows: PCBR-ed (50-ACATAATTATAACCTTACGGTCTG-30), PfCBR-ed (50-GATTTGTTCCGCTCAATAC-30), PvCBR-ed (50-CTG
TATTGTTCTGCTCAA-30), PoCBR-ed (50-CTGTATTGTTCTGCTCAT-30), PmCBR-ed (50-CTGTATTGTTCTGCACAG-30), PkCBR-ed (50-GTATTGTTCTAATCAGTGTA-30).
Nested PCR primers for the small-subunit rRNA from parasite nuclear DNA were the same as those reported by Kimura et al. [16] (gel not shown). The
inner PCR primer (reverse) used to amplify P. knowlesi DNA (SS-rRNA-Pk-R) had the following sequence: 50-AAGAGTTCTAATCTCCGGAGAGAAAAG-30 .
DNA sequences of the partial cytochrome b gene and SSU rRNA gene were deposited in the DNA Data Bank of Japan (DDBJ). The DDBJ accession
numbers of the DNA sequences of the partial cytochrome b gene and SSU rRNA gene were AB787188 and AB787187, respectively. A positive band for
the patient0s blood sample with P. knowlesi primer sets was shown.
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ical course of the mefloquine treatment in this patient
was as follows: the initial band-form and schizont-stage
parasites seen in the Giemsa-stained blood smears
disappeared six hours after administration of the drug
and, gradually, the shape of the ring-form parasites be-
came more irregular over time (Figure 1). The parasites
disappeared completely from the blood 40 hours later,
and the patient’s fever resolved 28 hours after meflo-
quine administration. The patient was discharged from
hospital on the seventh day post-admission, without any
complications. No relapses or any other health problems
were observed over a five-month period.
Conclusions
Most P. knowlesi infections are reported in the rural jun-
gle areas of the Malaysia peninsular and in Borneo
(Sabah [17] and Sarawak [2] province) where both of the
infectious hosts (macaque and leaf monkeys) and vectors
(Anopheles mosquitoes) predominantly exist. The patient
in this case was probably infected with P. knowlesi in the
Temengor jungle area as he had not entered any other
areas of jungle for four weeks before returning to Japan.
Interestingly, the incubation period in this patient was
probably over four weeks, which is longer than the nine
to 12 day incubation period reported for P. knowlesi
[18]. This finding is consistent with a case report for a
different traveller who also experienced a long incuba-
tion period (>17 days) [13]. Clinical data for P. knowlesi
infection in travellers are limited; therefore, more data
are needed to determine the correct incubation period
for P. knowlesi.No cases of treatment failure have been reported in travel-
lers treated with anti-malarial drugs such as quinine [4], doxy-
cycline [4], mefloquine [8], atovaquone/proguanil [5,10,14],
and artemether/lumefantrine [12]. In the present case, meflo-
quine enabled the patient to recover without any complica-
tions. Chloroquine has been usually used for uncomplicated P.
knowlesi infection [19]; however, in recent years, a prospective
comparative study suggested that early intravenous artemisinin
treatment improved the prognosis in severe cases of P.
knowlesi infection [17]. The major risk factors of increasing se-
verity are associated with a high parasitaemia [17,20] and
thrombocytopenia [20]. The risk factors of severity in P.
knowlesi infection should be evaluated appropriately, and if ne-
cessary, should be considered the intravenous artemisinin
treatment as other malaria parasite species [21].
Microscopic examination of Giemsa-stained blood
smears is the gold standard for differentiating Plasmodium
species; however, differentiating P. knowlesi from other
malaria species is very difficult because P. knowlesi band
forms and schizonts of mature trophozoites in P. knowlesi
are similar to those of P. malariae, while the ring forms of
P. knowlesi early trophozoites are similar to those of P.
falciparum [2,17,18]. This patient was initially suspected
of contracting P. malariae after observing his Giemsa-
stained thin blood smear (Figure 1). Although PCR is
required to obtain a definitive diagnosis, the spurious
amplification of a P. vivax gene using P. knowlesi-specific
primers has been reported [22]. In the present study, on
the other hand, a P. knowlesi gene was amplified using P.
vivax-specific primers [16]. These spurious amplifications
were observed when the target gene of PCR was the small
subunit rRNA gene [22] because of the similarity between
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caution is needed for using this gene to differentiate mal-
aria species by PCR. Indeed, some cases of P. knowlesi in-
fection in travellers have been initially diagnosed as P.
ovale [4] or P. vivax [13] by nested PCR; however, these
were later confirmed as P. knowlesi by DNA sequencing.
Therefore, DNA sequencing is indispensable for final con-
firmation of P. knowlesi infection.
There is limited access to DNA sequencing procedures for
identifying P. knowlesi in endemic areas. Hence, accurate
reporting of clinical and epidemiological data should contrib-
ute to better understanding of the clinical features of P.
knowlesi infection, as well as the true incidence of the dis-
ease. Close monitoring of febrile travellers returning from P.
knowlesi-endemic areas and complete travel histories (includ-
ing exposure to areas with wild monkeys) should prompt
suspicion of P. knowlesi infection [17] and a move towards
further diagnostic tests. Additionally, greater awareness of
the risk of the emerging P. knowlesi problem in travellers is
necessary among health care workers in non-endemic coun-
tries. Thus, reporting accurately diagnosed cases of P.
knowlesi infection in travellers would be important for
assessing the true nature of this emerging human infection.Consent
Oral informed consent was obtained from the patient
for publication of this case report and any accompanying
images after explanation of the report objectives.
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